Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
New York jury holds drug firm Teva liable in opioid crisis
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
Teva Wins UK Challenge Over Key Novartis Drug Patents (1)
The Difficulties of Cloning a CEO - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Tags search | Ctech
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva considering cutting up to 10,000 jobs: Bloomberg | Reuters
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
The Adderall supply squeeze in the US is growing
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
Buffett's Berkshire Takes Activision Blizzard Stake, Exits Teva - BNN Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva says its generic Adderall shortage will last another 2 to 3 months (NYSE:TEVA) | Seeking Alpha
Drugmaker Teva makes $40B bid for rival Mylan
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
